PDS Biotechnology Corporation Common Stock (NASDAQ: PDSB) last traded at $1.52, up 10.14% on the session. The quote above updates while this page is open; the figures below are drawn from PDS Biotechnology Corporation Common Stock’s own filings and are restated only when a new one is published.
PDS Biotechnology Corporation Common Stock trades on NASDAQ under the ticker PDSB. Its market capitalisation is $85.08 million.
Valuation measures for PDS Biotechnology Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $85.08M |
|---|---|
| Enterprise value | $91.87M |
| Beta | 2.70 |
Trailing-twelve-month figures tagged in PDS Biotechnology Corporation Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$33.67M |
|---|---|
| EPS (TTM) |
|---|
| -$0.630 |
| Cash | $5.60M |
|---|
Range and volume for PDSB over the past 52 weeks.
| 52-week high | $1.55 |
|---|---|
| 52-week low | $0.195 |
| Volume | 14.93M |
| Average volume | 23.49M |
| Previous close | $1.38 |
Invest a chosen dollar amount in PDS Biotechnology Corporation Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PDSB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.